StonvexLoading…
StonvexStonvexStonvexCore line items from BTCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.15M | $16.49M | $9.40M | $4.46M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $-69.16M | $-33.35M | $52.20M | $-13.39M |
EPS (Diluted) | $-1.43 | $-1.00 | $1.48 | $-0.65 |
Total Assets | $129.03M | $214.63M | $298.86M | $40.81M |
Total Liabilities | $56.92M | $75.22M | $73.45M | $9.74M |
Cash & Equivalents | $284.63K | $1.53M | $4.49M | $639.19K |
Free Cash Flow OCF − CapEx | Not available | $-9.80M | $-6.04M | $-3.24M |
Shares Outstanding | 49.78M | 46.85M | 47.08M | 21.97M |